tibolone has been researched along with Age-Related Osteoporosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.79) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 17 (58.62) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Fait, T | 1 |
| Elgebaly, Z; Elliott, J; Naik-Panvelkar, P; Norman, S; Pollack, A; Seibel, MJ; Thistlethwaite, J; Weston, C | 1 |
| Barik, A; Byram, PK; Chakravorty, N; Ray, SK; Sinha, R | 1 |
| Beckmann, MW; Bundred, NJ; Foidart, JM; Galta, RE; Kenemans, P; Kubista, E; Lieshout, EV; Mol-Arts, M; Planellas, J; Schoultz, Bv; Sismondi, P; Vassilopoulou-Sellin, R; Yip, CH | 1 |
| Biskobing, DM; Downs, R; Novy, AM | 1 |
| Krieg, MA; Lamy, O | 1 |
| Ederveen, AG; Kloosterboer, HJ | 3 |
| Bilezikian, JP; Rubin, MR | 1 |
| Lakatos, P | 1 |
| Bots, ML; Evans, GW; Grobbee, DE; Helmond, FA; McBride, KH; Meijer, R; Paskett, ED; Riley, W | 1 |
| Jin, Y; Kloosterboer, HJ; Oyesanmi, B; Penning, TM; Steckelbroeck, S | 1 |
| Bruce, D; Fentiman, I; McWilliams, S; Reddy, M; Robinson, J; Rymer, J | 1 |
| Jeong, KA; Lee, BS; Park, JH; Park, KH; Yoon, HK | 1 |
| Parfitt, AM; Riggs, BL | 1 |
| Bots, ML; Evans, GW; Grobbee, DE; Helmond, FA; McBride, KH; Paskett, ED; Riley, W | 1 |
| Qiao, L; Tian, Y; Xu, KH | 1 |
| Helmond, FA; Landgren, BM; Langer, RD; Rymer, J | 1 |
| Bors, K | 1 |
| Farish, E; Fletcher, CD; Hart, DM; Leggate, J; Lindsay, R | 1 |
| Coope, J | 1 |
| Schreiber, V; Stĕpán, JJ | 1 |
| Buhur, A; Burak, F; Kucuk, S; Taskin, O; Uryan, I; Yalcinoglu, AI | 1 |
| Luzuy, F; Martin-Du Pan, RC | 1 |
| Ederveen, AG; Kloosterboer, HJ; Quaijtaal, JH; Spanjers, CP | 1 |
| Goorissen, EM; Kicovic, PM; Tax, L | 1 |
| van der Vies, J | 1 |
9 review(s) available for tibolone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Novel therapeutic options for osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid | 2002 |
[Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
Topics: Aged; Bone Density; Bone Resorption; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Osteoporosis; Randomized Controlled Trials as Topic | 2002 |
Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.
Topics: Bone and Bones; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Humans; Models, Chemical; Norpregnenes; Osteoporosis; Postmenopause; Progestins; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2002 |
New anabolic therapies in osteoporosis.
Topics: Aged; Bone and Bones; Bone Density; Female; Fluorides; Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin-Like Growth Factor I; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Strontium | 2003 |
[Treatment of osteoporosis].
Topics: Bone Density; Calcitonin; Calcium Compounds; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Male; Norpregnenes; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D | 2003 |
Osteoporosis in Korea.
Topics: Absorptiometry, Photon; Biomarkers; Calcitonin; Calcitriol; Calcium, Dietary; Diagnostic Imaging; Diphosphonates; Estrogen Replacement Therapy; Exercise; Female; Hip Fractures; Humans; Korea; Male; Norpregnenes; Osteoporosis; Prevalence; Selective Estrogen Receptor Modulators; Smoking Cessation | 2004 |
Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
Topics: Adult; Age Factors; Aged; Aging; Anabolic Agents; Bone and Bones; Bone Density; Bone Development; Bone Remodeling; Bone Resorption; Female; Humans; Middle Aged; Models, Biological; Norpregnenes; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Terminology as Topic; Testosterone; Thiophenes; Time Factors | 2005 |
[Up-to-date treatments for osteoporosis].
Topics: Bone Density; Bone Density Conservation Agents; Bone Regeneration; Calcitonin; Calcium Compounds; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Fluorides; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Testosterone; Thiophenes; Vitamin D | 2006 |
[What's new in hormone replacement therapy for postmenopausal women? I. Advantages of hormone replacement therapy (HRT)].
Topics: Aged; Alzheimer Disease; Cardiovascular Diseases; Cholesterol, HDL; Depression; Dyspareunia; Estrogen Replacement Therapy; Female; Humans; Male; Megestrol; Middle Aged; Norpregnenes; Osteoporosis; Postmenopause; Progesterone Congeners | 2000 |
6 trial(s) available for tibolone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.
Topics: Adult; Aged; Analysis of Variance; Body Mass Index; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis; Selective Estrogen Receptor Modulators; Survivors | 2012 |
The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics.
Topics: Aged; Bone Density; Carotid Arteries; Disease Progression; Double-Blind Method; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norpregnenes; Osteoporosis; Postmenopause; Random Allocation; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Ultrasonography | 2003 |
The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Topics: Aged; Atherosclerosis; Double-Blind Method; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Treatment Outcome; Tunica Intima; Tunica Media | 2006 |
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage | 2006 |
Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.
Topics: Adult; Anabolic Agents; Double-Blind Method; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Norpregnenes; Osteoporosis; Prospective Studies | 1997 |
Clinical profile of Org OD 14.
Topics: Carbohydrate Metabolism; Climacteric; Clinical Trials as Topic; Endometrium; Female; Hemostasis; Hormones; Humans; Kinetics; Lipid Metabolism; Norpregnenes; Osteoporosis; Receptors, Steroid | 1987 |
14 other study(ies) available for tibolone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Tibolon - the only one member of STEARs group.
Topics: Breast Neoplasms; Climate; Estrogen Receptor Modulators; Estrogens; Female; Humans; Menopause; Norpregnenes; Osteoporosis; Progestins | 2019 |
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
Topics: Aged; Aged, 80 and over; Attitude of Health Personnel; Australia; Bone Density Conservation Agents; Denosumab; Deprescriptions; Diphosphonates; Drug Substitution; Female; General Practice; General Practitioners; Humans; Longitudinal Studies; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporotic Fractures; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Retrospective Studies; Teriparatide; Thiophenes | 2020 |
Extensive early mineralization of pre-osteoblasts, inhibition of osteoclastogenesis and faster peri-implant bone healing in osteoporotic rat model: principle effectiveness of bone-specific delivery of Tibolone as evaluated in vitro and in vivo.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Regeneration; Bone Resorption; Cell Line, Tumor; Cell Survival; Curcumin; Drug Delivery Systems; Female; Humans; In Vitro Techniques; Metals; Mice; Norpregnenes; Osteoblasts; Osteogenesis; Osteoporosis; Ovariectomy; Prostheses and Implants; Rats; Rats, Wistar; RAW 264.7 Cells; Surface Properties; Titanium | 2020 |
Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid.
Topics: 20-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Estrogen Receptor Modulators; Humans; Isoenzymes; Ketosteroids; Kinetics; Norpregnenes; Osteoporosis; Recombinant Proteins; Substrate Specificity | 2004 |
Long-term effects of tibolone on mammographic density.
Topics: Administration, Oral; Breast; Case-Control Studies; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Mammography; Middle Aged; Norpregnenes; Osteoporosis; Pilot Projects; Single-Blind Method | 2004 |
[Comparative study of effects of hormonal therapies on the healing of fracture in ovariectomized rats and Rats' endometria].
Topics: Animals; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Female; Femoral Fractures; Fracture Healing; Norpregnenes; Osteoporosis; Random Allocation; Rats; Rats, Sprague-Dawley | 2006 |
Org OD 14: long-term effects on serum lipoproteins.
Topics: Cholesterol; Female; Humans; Lipoproteins; Menopause; Middle Aged; Norpregnenes; Osteoporosis; Time Factors; Triglycerides | 1984 |
Trial of synthetic steroid for preventing postmenopausal osteoporosis.
Topics: Anabolic Agents; Body Weight; Female; Humans; Menopause; Norpregnenes; Osteoporosis | 1980 |
Anabolic effects of progestogens in bone remodelling.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Female; Follow-Up Studies; Humans; Hydroxyproline; Norethindrone; Norpregnenes; Osteoporosis; Ovariectomy; Progestins; Prospective Studies | 1995 |
Tibolone. KB 889, ORG OD 14, ORG OD14, Livial, Livifem, Boltin.
Topics: Anabolic Agents; Drug Interactions; Drugs, Investigational; Female; Hormone Replacement Therapy; Hormones; Humans; Norpregnenes; Osteoporosis | 1999 |
Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
Topics: Anabolic Agents; Animals; Body Weight; Bone Density; Estrogens; Female; Humans; Norpregnenes; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Sexual Maturation | 1999 |
Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Topics: Amino Acids; Anabolic Agents; Androgen Antagonists; Animals; Biomarkers; Bone and Bones; Bone Density; Creatinine; Estrogen Receptor Modulators; Female; Norpregnenes; Osteocalcin; Osteoporosis; Ovariectomy; Progestins; Rats; Rats, Wistar; Receptors, Estrogen | 2001 |
Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
Topics: Alkaline Phosphatase; Amino Acids; Anabolic Agents; Animals; Biomarkers; Bone Density; Creatinine; Disease Models, Animal; Female; Femur; Liver; Norpregnenes; Osteocalcin; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Tibia; Time Factors | 2001 |
Pharmacological studies with (7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14).
Topics: Androgens; Animals; Estrogens; Female; Genitalia, Male; Male; Norpregnenes; Organ Size; Osteoporosis; Ovulation; Progestins; Rabbits; Rats; Sexual Behavior, Animal; Uterus; Vagina | 1987 |